Sexual Dysfunction in First-Episode Schizophrenia Patients. Results From European First Episode Schizophrenia Trial

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F11%3A10104348" target="_blank" >RIV/00179906:_____/11:10104348 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/11:10104348

Výsledek na webu

<a href="http://dx.doi.org/10.1097/JCP.0b013e3182199bcc" target="_blank" >http://dx.doi.org/10.1097/JCP.0b013e3182199bcc</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1097/JCP.0b013e3182199bcc" target="_blank" >10.1097/JCP.0b013e3182199bcc</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Sexual Dysfunction in First-Episode Schizophrenia Patients. Results From European First Episode Schizophrenia Trial

Popis výsledku v původním jazyce

Sexual dysfunctions (SDs) occur frequently in schizophrenia patients and have a huge impact on quality of life and compliance. They are often associated with antipsychotic medication. Nicotine consumption, negative or depressive symptoms, and physical illness are also discussed as contributing factors. Data on SD in first-episode schizophrenia patients are scarce.As part of the European First Episode Schizophrenia Trial, first-episode schizophrenia patients were randomly assigned to 5 medication groups.We assessed SD by analyzing selected items from the Udvalg for Kliniske Undersugelser at baseline and at 5 following visits.Differences between antipsychotics were small for all SDs, and fairly little change in the prevalence of SDs was seen over the course of the study. A significantly larger increase of amenorrhea and galactorrhea was seen with amisulpride than with the other medications. In men, higher age, more pronounced Positive and Negative Syndrome Scale general psychopathology

Název v anglickém jazyce

Sexual Dysfunction in First-Episode Schizophrenia Patients. Results From European First Episode Schizophrenia Trial

Popis výsledku anglicky

Sexual dysfunctions (SDs) occur frequently in schizophrenia patients and have a huge impact on quality of life and compliance. They are often associated with antipsychotic medication. Nicotine consumption, negative or depressive symptoms, and physical illness are also discussed as contributing factors. Data on SD in first-episode schizophrenia patients are scarce.As part of the European First Episode Schizophrenia Trial, first-episode schizophrenia patients were randomly assigned to 5 medication groups.We assessed SD by analyzing selected items from the Udvalg for Kliniske Undersugelser at baseline and at 5 following visits.Differences between antipsychotics were small for all SDs, and fairly little change in the prevalence of SDs was seen over the course of the study. A significantly larger increase of amenorrhea and galactorrhea was seen with amisulpride than with the other medications. In men, higher age, more pronounced Positive and Negative Syndrome Scale general psychopathology

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FL - Psychiatrie, sexuologie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Clinical Psychopharmacology

ISSN

0271-0749

e-ISSN

—

Svazek periodika

31

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

7

Strana od-do

274-280

Kód UT WoS článku

000290033100003

EID výsledku v databázi Scopus

—